Ethnicity is an independent determinant of age-specific PSA level: Findings from a multiethnic Asian setting - Abstract

OBJECTIVES: To study the baseline PSA profile and determine the factors influencing the PSA levels within a multiethnic Asian setting.

MATERIALS AND METHODS: We conducted a cross-sectional study of 1054 men with no clinical evidence of prostate cancer, prostate surgery or 5α-reductase inhibitor treatment of known prostate conditions. The serum PSA concentration of each subject was assayed. Potential factors associated with PSA level including age, ethnicity, height, weight, family history of prostate cancer, lower urinary tract voiding symptoms (LUTS), prostate volume and digital rectal examination (DRE) were evaluated using univariable and multivariable analysis.

RESULTS: There were 38 men (3.6%) found to have a PSA level above 4 ng/ml and 1016 (96.4%) with a healthy PSA (≤ 4 ng/ml). The median PSA level of Malay, Chinese and Indian men was 1.00 ng/ml, 1.16 ng/ml and 0.83 ng/ml, respectively. Indians had a relatively lower median PSA level and prostate volume than Malays and Chinese, who shared a comparable median PSA value across all 10-years age groups. The PSA density was fairly similar amongst all ethnicities. Further analysis showed that ethnicity, weight and prostate volume were independent factors associated with age specific PSA level in the multivariable analysis (p< 0.05).

CONCLUSION: These findings support the concept that the baseline PSA level varies between different ethnicities across all age groups. In addition to age and prostate volume, ethnicity may also need to be taken into account when investigating serum PSA concentrations in the multiethnic Asian population.

Written by:
Lim J, Bhoo-Pathy N, Sothilingam S, Malek R, Sundram M, Hisham Bahadzor B, Ong TA, Ng KL, Sivalingam S, Razack AH.   Are you the author?
Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Julius Center University of Malaya, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Urology, Tuanku Mizan Military Hospital, Kuala Lumpur, Malaysia; Department of Urology, Selayang Hospital, Selangor, Malaysia; Department of Urology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia; Department of Surgery, University Kebangsaan Malaysia Medical Center, Kuala Lumpur, Malaysia; Centre for Kidney Disease Research, School of Medicine, University of Queensland, Translational Research Institute, Brisbane, Australia.

Reference: PLoS One. 2014 Aug 11;9(8):e104917.
doi: 10.1371/journal.pone.0104917


PubMed Abstract
PMID: 25111507

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe